Eli Lilly's Foundayo: Game-Changer in Weight Loss Pill Market
Business & Finance News Today | 2 Min News | The Daily News Now! · The Daily News Now!
Audio is streamed directly from the publisher (api.fastcast.ai) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Eli Lillys new weight-loss pill, Foundayo, is poised to disrupt the market, with analysts predicting sales ranging from $1.5 billion to $2.8 billion in 2026. The pills ease of manufacturing and fewer dosing limits make it a formidable competitor to Novo Nordisks offerings. While Novos Wegovy holds an early lead, the rivalry is heating up as Foundayo gains momentum.
Support the show:
Get a discount at https://solipillow.com/discount/dnn.
Advertise on DNN:
[email protected]
This is an automated, high-level news summary based on public reporting.
Report issues to [email protected].
View sources & latest updates:
https://sources.thednn.ai/4e65dc8dceb578e6